Primary Cutaneous NK /T‐Cell Lymphoma With Aberrant CD20 Expression Responsive to SMILE Chemotherapy
Year: 2025
Type: article
Abstract: The authors declare no conflicts of interest. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Source: Journal of Cutaneous Pathology
DOI: 10.1111/cup.70017
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4416441355
